期刊文献+

Prader-Willi综合征不同时期临床特征分析

Analysis of the clinical characteristics of Prader-Willi syndrome in different stages
下载PDF
导出
摘要 目的分析Prader-Willi综合征(Prader-Willi syndrome,PWS)不同时期的临床特点,以提高临床医生对PWS的认知。方法收集2019年1月至2022年2月在郴州市第一人民医院内分泌科收治的11例经过基因诊断为PWS患儿的临床资料,其中男性7例,女性4例;于我院初次就诊的年龄为1 d~15岁。其中新生儿期6例,幼儿期1例,学龄期3例,青春期1例。分析11例患儿的临床表现、超声特点及诊治过程,总结其临床特点。结果11例PWS患儿中,10例在新生儿时期出现肌张力减退、喂养困难,所有男孩出生时都有隐睾(其中5例双侧隐睾,2例右侧隐睾)。5例患儿出生时出现动脉导管未闭合并卵圆孔未闭,3例仅为卵圆孔未闭。1例青春期患儿出现青春发育延迟合并糖尿病。11例PWS均经过基因检测确诊,1例为母源性单亲二倍体,其余10例为父源缺失型。3例患儿使用生长激素治疗,3例因反复发热暂未启动生长激素治疗,1例予以司美格鲁肽联合达格列净降糖治疗,3例因经济条件未能治疗,1例行隐睾手术,1例已死亡。结论新生儿出现张力减退、喂养困难,特别是合并隐睾,或自幼肥胖、身材矮小,伴糖尿病、性腺发育异常的患儿,需高度怀疑PWS诊断。新生儿期心脏缺陷也是其重要特征。确诊后应尽早使用生长激素治疗,长效GLP-1受体激动剂和SGLT2抑制剂可能成为PWS合并糖尿病治疗的一种新选择。 Objective To enhance the early recognition of Prader-Willi syndrome(PWS)by analyzing the clinical characteristics and misdiagnosis of PWS during different stages.Methods The clinical data of 11 children who were genetically diagnosed with PWS in the Department of Endocrinology,the First People's Hospital of Chenzhou from January 2019 to February 2022 were collected,including 7 males and 4 females.The age of first visit in our hospital ranged from 1 day to 15 years.There were 6 cases in neonatal period,1 case in early childhood,3 cases in school age,and 1 case in adolescence.The clinical manifestations,ultrasound features,diagnosis and treatment of the 11 patients were analyzed,and the clinical characteristics were summarized.Results Among the 11 PWS patients,1 was maternal diploid and the other 10 had paternal deletion.Ten patients manifested hypotonia and feeding difficulties during neonatal period,and all males were born with cryptorchidism(5 with bilateral cryptorchidism and 2 with right cryptorchidism).Five patients were born with both patent ductus arteriosus and patent foramen ovale,and three patients were born with patent foramen ovale only.One adolescent patient had delayed appearance of secondary sex characteristics and diabetes mellitus.Three patients were treated with growth hormone,3 patients were not treated with growth hormone because of recurrent fever,1 patient was treated with semaglutide combined with dapagliflozin,3 patients were not treated due to economic conditions,1 patient underwent cryptorchidism surgery,and 1 patient died.Conclusion PWS should be highly suspected in neonates with hypotonia and feeding difficulties,especially for those with cryptorchidism,obesity,short stature,diabetes and gonadal dysplasia.Heart defects in neonatal period are also important features.After diagnosis,growth hormone therapy should be used as soon as possible,long-acting GLP-1 agonists and SGLT2 inhibitors may be new options for the treatment of diabetes in PWS.
作者 骆宁 刘畅 彭丽华 李甘 谭菊芳 LUO Ning;LIU Chang;PENG Lihua;LI Gan;TAN Jufang(Department of Endocrinology,Chenzhou First People's Hospital,Chenzhou 423000,China;Department of Laboratory,Chenzhou Fourth People's Hospital,Chenzhou 423000,China;Department of Nutrition,Chenzhou First People's Hospital,Chenzhou 423000,China;Department of Rare Diseases,Chenzhou First People's Hospital,Chenzhou 423000,China)
出处 《大连医科大学学报》 CAS 2023年第2期129-133,共5页 Journal of Dalian Medical University
基金 郴州市科技局项目(lcy12021035)。
关键词 PRADER-WILLI综合征 糖尿病 GLP-1受体激动剂 SGLT2抑制剂 Prader-Willi syndrome diabetes mellitus GLP-1 receptor agonists SGLT2 inhibitors
  • 相关文献

参考文献1

二级参考文献39

  • 1Prader A, Labhart A, Willi H. Ein Syndrom von Adipositas, Kleinwuehs, Kryptorchismus und Oligophrenia nach myatonieartigem Zustand im Neugeborenenaher [ J]. Schweiz Med Wochenschr, 1956, 86: 1260-1261.
  • 2McCandless SE; Committee on Genetics. Clinical report- health supervision for children with Prader-Willi syndrome [ J ]. Pediatrics, 2011, 127 ( 1 ) :195-204.
  • 3Cassidy SB, Schwartz S, Miller JL, et al. Prader-Willi syndrome[J]. Genet Med, 2012, 14 (1): 10-26.
  • 4Buffer MG. Pmder-Willi syndrome: obesity due to genomic imprinting [J]. Curr Genomics, 2011, 12 (3): 204-215.
  • 5Goldstone AP, Holland AJ, Hauffa BP, et al. Recommendations for the diagnosis and management of Prader-Willi syndrome [ J]. J Clin Endocfinol Metab, 2008, 93 (11) : 4183-4197.
  • 6Diene G, Mimoun E, Feigerlova E, et al. Endocrine dimmers in children with Pratter-Willi syndrome- data from 142 ehiidrert of the French database [J]. Horm Res Paediatr, 2010, 74 (2) : 121- 128.
  • 7Emerick JE, Vogt KS. Endocrine manifestations and management of Prader-Willi syndrome [ J ]. Int J Pediatr Endocrinol, 2013, 2013 (1): 14.
  • 8Lu W, Qi Y, Cui B, et al. Clinical and genetic features of Prader- Willi syndrome in China [ J]. Eur J Pediatr, 2014, 173 ( 1 ) : 81 - 86.
  • 9Ma Y, Wu T, Liu Y, ct al. Nutritional and metabolic findings in patients with Prader-Willi syndrome diagnosed in early infancy [J]. J Pediatr Endocrinol Metal), 2012, 25 (11-12): 1103- 1109.
  • 10Ehara H, Ohno K, Takeshita K. Frequency of the Prader-WiUi syndrome in the San-in district, Japan [J]. Brain Dev, 1995, 17 (5) : 324-326.

共引文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部